RSA Viewpoints
RSA’s Chris Molloy and Nick Stephens speaking at the Pharma Integrates Conferences – November 2015
Chris Molloy talks about the future of ‘big data’ in Pharma (INSERT VIDEO) Nick Stephens on ‘The people ingredient: mapping Pharma’s future’ (INSERT...
Talent: the key to biotech value creation
Everyone’s happy to talk about how important talent is to tech and life sciences companies but when it comes to valuation the financial community...
Avoid firing through better hiring
Luke Johnson, the serial entrepreneur and investor made a critical insight in his recent column in the Sunday Times. He wrote about how difficult and costly it...
Specialised Skills and Total Focus Driving Orphan Growth
By Chris Molloy, CEO of RSA, the world’s largest Talent Consultancy dedicated to the Life Sciences industry. It’s easy to be patient-focused when you’re...
Due diligence needed in exec hiring: the difference between success and failure
We recently showed the cost of making bad senior hires, with 48% going wrong in the first 18 months. To remind you of the enormity of...
Hiring new talent – it pays to be diligent
Companies hire new senior talent to fuel corporate success. Too often it proves to be an expensive failure. New data from Leadership IQ1 across...
Transformational leadership for Singapore health initiative
Investment in oral health The 23rd September 2015 saw the ground breaking for a new Institute of Oral Health in Singapore. We believe that this...
The executive interim community calls for a ‘conscious coupling’ of RPOs and interims specialists
A voice of choice is emerging from the executive interim community and this is as encouraging as it is concerning. Online forums are rife...
It’s a seller’s market
How the world has changed Twelve months’ ago the life sciences executive search market was driven by employers, the market was recovering from three...
Lowering the business risk of hiring senior talent
Hiring the wrong people into senior positions is a big financial and reputational risk. Recent research shows that 48% of new hires fail within...
New management talent needed to support biotech renaissance
2014 saw VCs plough $6.55bn into the biotech sector, with Europe alone seeing a year-on-year increase of $1.24bn. The figures tell a story of...
Talent: The Key to Biotech Value Creation
By Chris Molloy, CEO of RSA and first published in EPC in September 2015 and posted to the RSA website on 03.09.2015. Without exceptional...
RSA Launches ‘RSA Talent Equity Reports’
Reports highlight importance of People & Skills as a vital addition to Assets & Investments. RSA, the leading global Life Sciences Executive Search and...
Life Sciences in Asia: is the Tiger an Endangered Species?
Published in Recruitment International Asia in April 2015. The story of Western expansion into the Life Sciences in Asia has been one of rapid...
What’s Wrong with the Search Consultant-Client Relationship? Who is in Charge Here?
This article by Chris Molloy, CEO of RSA, first appeared on Recruitment International on 3rd February 2015. I just heard a senior exec say...
The Hunt for Talent in Asia: Mind the (Generation) Gap
As more global life sciences firms see their Asian businesses skyrocket, the search for strong, internationally savvy talent in Asia-Pacific has never been more...